NCT05380986 2022-05-19Camrelizumab Combined With Apatinib MesylateHenan Cancer HospitalPhase NA Unknown500 enrolled
NCT04832204 2021-04-05Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver MetastasesBeijing HospitalPhase 2 Unknown20 enrolled